Abstract
The tumour suppressor gene RASSF1A is frequently silenced in lung cancer and other sporadic tumours as a result of hypermethylation of a CpG island in its promoter1,2,3,4,5,6. However, the precise mechanism by which RASSF1A functions in cell cycle regulation and tumour suppression has remained unknown. Here we show that RASSF1A regulates the stability of mitotic cyclins and the timing of mitotic progression. RASSF1A localizes to microtubules during interphase and to centrosomes and the spindle during mitosis. The overexpression of RASSF1A induced stabilization of mitotic cyclins and mitotic arrest at prometaphase. RASSF1A interacts with Cdc20, an activator of the anaphase-promoting complex (APC), resulting in the inhibition of APC activity. Although RASSF1A does not contribute to either the Mad2-dependent spindle assembly checkpoint or the function of Emi1 (ref. 1), depletion of RASSF1A by RNA interference accelerated the mitotic cyclin degradation and mitotic progression as a result of premature APC activation. It also caused a cell division defect characterized by centrosome abnormalities and multipolar spindles. These findings implicate RASSF1A in the regulation of both APC–Cdc20 activity and mitotic progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dammann, R. et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genet. 25, 315–319 (2000).
Astuti, D. et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 20, 7573–7577 (2001).
Burbee, D.G. et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93, 691–699 (2001).
Dammann, R., Takahashi, T. & Pfeifer, G.P. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20, 3563–3567 (2001).
Dreijerink, K. et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl Acad. Sci. USA 98, 7504–7509 (2001).
Lo, K.W. et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 61, 3877–3881 (2001).
King, R.W., Deshaies, R.J., Peters, J.M. & Kirschner, M.W. How proteolysis drives the cell cycle. Science 274, 1652–1659 (1996).
Zachariae, W. & Nasmyth, K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev. 13, 2039–2058 (1999).
Jallepalli, P.V. & Lengauer, C. Chromosome segregation and cancer: cutting through the mystery. Nature Rev. Cancer 1, 109–117 (2001).
Peters, J.M. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9, 931–943 (2002).
Visintin, R., Prinz, S. & Amon, A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278, 460–463 (1997).
Reimann, J.D., Gardner, B.E., Margottin-Goguet, F. & Jackson, P.K. Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15, 3278–3285 (2001).
Reimann, J.D. et al. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105, 645–655 (2001).
Hsu, J.Y., Reimann, J.D., Sorensen, C.S., Lukas, J. & Jackson, P.K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nature Cell Biol. 4, 358–366 (2002).
Vos, M.D., Ellis, C.A., Bell, A., Birrer, M.J. & Clark, G.J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275, 35669–35672 (2000).
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R. & White, M.A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22, 4309–4318 (2002).
Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813–826 (2003).
Zhang, Y. & Lees, E. Identification of an overlapping binding domain on Cdc20 for Mad2 and anaphase-promoting complex: model for spindle checkpoint regulation. Mol. Cell. Biol. 21, 5190–5199 (2001).
Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553 (2002).
Luo, X., Tang, Z., Rizo, J. & Yu, H. The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20. Mol. Cell 9, 59–71 (2002).
Martin-Lluesma, S., Stucke, V.M. & Nigg, E.A. Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297, 2267–2270 (2002).
Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799–812 (2003).
Raff, J.W., Jeffers, K. & Huang, J.Y. The roles of Fzy/Cdc20 and Fzr/Cdh1 in regulating the destruction of cyclin B in space and time. J. Cell Biol. 157, 1139–1149 (2002).
Cahill, D.P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998).
Fodde, R. et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nature Cell Biol. 3, 433–438 (2001).
Kaplan, K.B. et al. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nature Cell Biol. 3, 429–432 (2001).
Jallepalli, P.V. et al. Securin is required for chromosomal stability in human cells. Cell 105, 445–457 (2001).
Lim, D.S. et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404, 613–617 (2000).
Fang, G., Yu, H. & Kirschner, M.W. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev. 12, 1871–1883 (1998).
Buschmann, T., Fuchs, S.Y., Lee, C.G., Pan, Z.Q. & Ronai, Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101, 753–762 (2000).
Acknowledgements
We thank M. White and C. H. Lee for RASSF1A and Cdc20 cDNAs, respectively, and B. S. Suh for comments on the manuscript. This work was supported by grants from the 21st Century Frontier Functional Human Genome Project of KISTEP (Ministry of Science and Technology of Korea) and the Biomedical Research Program of KISTEP to D.-S.L., by a grant from the National Creative Research Program of KISTEP to E.-J.C, and by a grant from the Korea Health 21 R&D Project (02-PJ-PG10-20802-0012) to H.K. D.-S.L. was also supported by a grant from the Korea National Cancer Center Control Program (0320370-1).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary figures
Supplementary Information, Fig. S1 (PDF 282 kb)
Supplementary Information, Fig. S2
Supplementary Information, Fig. S3
Rights and permissions
About this article
Cite this article
Song, M., Song, S., Ayad, N. et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex. Nat Cell Biol 6, 129–137 (2004). https://doi.org/10.1038/ncb1091
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb1091
This article is cited by
-
Biomarkers of disease recurrence in stage I testicular germ cell tumours
Nature Reviews Urology (2022)
-
Arsenic concentration in topsoil of central Chile is associated with aberrant methylation of P53 gene in human blood cells: a cross-sectional study
Environmental Science and Pollution Research (2022)
-
NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells
Journal of Experimental & Clinical Cancer Research (2019)
-
RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis—an updated review
Cell Death & Disease (2019)
-
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation
Cell Death & Differentiation (2019)